Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Total Debt (2020 - 2025)

Maravai Lifesciences Holdings has reported Total Debt over the past 6 years, most recently at $291.8 million for Q4 2025.

  • Quarterly results put Total Debt at $291.8 million for Q4 2025, down 1.41% from a year ago — trailing twelve months through Dec 2025 was $291.8 million (down 1.41% YoY), and the annual figure for FY2025 was $291.8 million, down 1.41%.
  • Total Debt for Q4 2025 was $291.8 million at Maravai Lifesciences Holdings, roughly flat from $292.8 million in the prior quarter.
  • Over the last five years, Total Debt for MRVI hit a ceiling of $748.3 million in Q4 2021 and a floor of $291.8 million in Q4 2025.
  • Median Total Debt over the past 5 years was $524.6 million (2023), compared with a mean of $502.0 million.
  • Biggest five-year swings in Total Debt: surged 94.44% in 2022 and later tumbled 43.87% in 2025.
  • Maravai Lifesciences Holdings' Total Debt stood at $748.3 million in 2021, then fell by 29.52% to $527.4 million in 2022, then dropped by 0.62% to $524.1 million in 2023, then tumbled by 43.54% to $295.9 million in 2024, then fell by 1.41% to $291.8 million in 2025.
  • The last three reported values for Total Debt were $291.8 million (Q4 2025), $292.8 million (Q3 2025), and $293.9 million (Q2 2025) per Business Quant data.